​

Funding Round

Series B - ROME Therapeutics

Series B - ROME Therapeutics

Investment Firm

Overview

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Announced Date

Sep 12, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

13

Investor Name
Participant InvestorSanofi Ventures
Participant InvestorBristol-Myers Squibb
Participant InvestorSection 32
Participant InvestorAndreessen Horowitz
Participant InvestorGoogle Ventures

Round Details and Background

ROME Therapeutics raised $72000000 on 2023-09-12 in Series B

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 27, 2020
Series A - ROME Therapeutics
3-50.0M
Sep 14, 2021
Series B - ROME Therapeutics
8-77.0M
Sep 12, 2023
Series B - ROME Therapeutics
16-72.0M

Recent Activity

There is no recent news or activity for this profile.